Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 May;4(3):205–208. doi: 10.1155/S0962935195000330

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388

J Góra-Tybor 1, K Warzocha 2, T Robak 2,✉
PMCID: PMC2365631  PMID: 18475640

Abstract

We investigated the influence of 2-chlorodeoxyadenosine (2-CdA) in combination with tumour necrosis factor-α (TNFα) or its mutein VI, which differs from the native molecule by N-terminal amino acid composition, on the survival time of mice inoculated with leukaemia L1210 or P388. Groups of mice with leukaemia L1210 and P388 receiving 2-CdA combined with TNFα had shorter survival times than animals treated with these agents separately. In contrast, the administration of 2-CdA in conjunction with mutein VI, prolonged the survival of mice inoculated with these leukaemias as compared with animals receiving these agents separately. The results of the present study emphasize the importance of the biological activity of the TNFα molecule N-terminus.

Full Text

The Full Text of this article is available as a PDF (359.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnet P. A., Robins R. K. Modulation of leukocyte genetic expression by novel purine nucleoside analogues. A new approach to antitumor and antiviral agents. J Med Chem. 1993 Mar 19;36(6):635–653. doi: 10.1021/jm00058a001. [DOI] [PubMed] [Google Scholar]
  2. Brach M. A., Herrmann F., Kufe D. W. Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells. Blood. 1992 Feb 1;79(3):728–734. [PubMed] [Google Scholar]
  3. Góra-Tybor J., Robak T. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388. Acta Haematol Pol. 1993;24(2):177–182. [PubMed] [Google Scholar]
  4. Kłysik J., Konarzewska-Zglińska A., Gałazka G., Uznański B., Okruszek A., Guga P., Wilk A., Koziołkiewicz M., Tchórzewski H., Zembala M. Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF). Arch Immunol Ther Exp (Warsz) 1991;39(4):349–355. [PubMed] [Google Scholar]
  5. Loetscher H., Steinmetz M., Lesslauer W. Tumor necrosis factor: receptors and inhibitors. Cancer Cells. 1991 Jun;3(6):221–226. [PubMed] [Google Scholar]
  6. Robak T., Korycka A., Góra-Tybor J. The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro. Leuk Res. 1994 Apr;18(4):275–281. doi: 10.1016/0145-2126(94)90030-2. [DOI] [PubMed] [Google Scholar]
  7. Robertson L. E., Chubb S., Meyn R. E., Story M., Ford R., Hittelman W. N., Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine. Blood. 1993 Jan 1;81(1):143–150. [PubMed] [Google Scholar]
  8. Schütze S., Machleidt T., Krönke M. Mechanisms of tumor necrosis factor action. Semin Oncol. 1992 Apr;19(2 Suppl 4):16–24. [PubMed] [Google Scholar]
  9. Tartaglia L. A., Goeddel D. V. Two TNF receptors. Immunol Today. 1992 May;13(5):151–153. doi: 10.1016/0167-5699(92)90116-O. [DOI] [PubMed] [Google Scholar]
  10. Tchorzewski H., Zeman K., Kantorski J., Paleolog E., Kahan M., Feldmann M., Kwinkowski M., Guga P., Szymanska B., Parniewski P. The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro. Mediators Inflamm. 1993;2(1):41–48. doi: 10.1155/S0962935193000055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tchorzewski H., Zeman K., Paleolog E., Brennan F., Feldmann M., Kahan M., Guga P., Kwinkowski M., Szymanska B., Jarosz J. The effects of tumor necrosis factor (TNF) derivatives on TNF receptors. Cytokine. 1993 Mar;5(2):125–132. doi: 10.1016/1043-4666(93)90051-6. [DOI] [PubMed] [Google Scholar]
  12. Warzocha K., Góra-Tybor J., Kwinkowski M., Szymańska B., Robak T. A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice. Mediators Inflamm. 1994;3(6):411–414. doi: 10.1155/S0962935194000578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Winkelhake J. L., Stampfl S., Zimmerman R. J. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Cancer Res. 1987 Aug 1;47(15):3948–3953. [PubMed] [Google Scholar]
  14. Wyllie A. H. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer. 1993 Feb;67(2):205–208. doi: 10.1038/bjc.1993.40. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES